Sector: Health Care
Director information for TEMPUS AI INC CLASS A (data for year 2026)
| Name | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| David R. Epstein | Director | 64 | ["Chairman and CEO of Ottimo Pharma Limited since October 2024","Board member at Valo Health, LLC and Agomab Therapeutics NV","Director at Three Opinions Foundation Inc and Pelican Harbor Seabird Station","Former CEO and board member of Seagen Inc.","Leadership roles at multiple biotherapeutics companies","B.S. in pharmacy from Rutgers University College of Pharmacy","M.B.A. in finance and marketing from Columbia University Graduate School of Business","Extensive experience in executive roles in the life sciences industry"] | ["Compensation Committee","Nominating and Corporate Governance Committee"] | 2026 |
| Eric D. Belcher | Director | 57 | ["extensive experience in the technology industry","leading high growth companies"] | ["Audit Committee"] | 2026 |
| Eric Lefkofsky | Founder, Chief Executive Officer, Chairman; Observer; Chief Executive Officer, Founder and Director | 56 | ["Founder and Chief Executive Officer of Tempus","Co-founded Groupon, Inc.","Managing member at Lightbank LLC","Co-founded InnerWorkings, Inc.","Co-founded Mediaocean, LLC","Co-founded Echo Global Logistics, Inc.","Co-founded Pathos AI, Inc.","Board member of Northwestern Memorial Healthcare since February 2024","Bachelor's degree from University of Michigan","J.D. from University of Michigan Law School"] | ["Executive Committee","Nominating and Corporate Governance Committee"] | 2026 |
| Jennifer A. Doudna, Ph.D. | Director | 62 | ["Professor of Biochemistry & Molecular Biology","directs the Innovative Genomics Institute"] | ["Nominating and Corporate Governance Committee"] | 2026 |
| Nadja West, M.D. | Director | 65 | ["Member of the board of directors of Johnson & Johnson since December 2020","Member of the board of directors of Tenet Healthcare Corp since October 2019","Member of the board of directors of Nucor Corporation since September 2019","44th Surgeon General of the U.S. Army from December 2015 to October 2019","Commanding General of the U.S. Army Medical Command","Trustee of the National Recreation Foundation and Mount St. Mary’s University","Board member of The Woodruff Foundation","Independent member of the NCAA Board of Governors","B.S. from the United States Military Academy at West Point","M.D. from The George Washington University School of Medicine","M.S. from National War College","Executive and operational leadership","Expertise with strategic planning and healthcare management"] | ["Compensation Committee"] | 2026 |
| Peter J. Barris | Director | 74 | ["investment management and financial expertise","experience serving on public company boards"] | ["Audit Committee","Compensation Committee","Executive Committee"] | 2026 |
| Scott Gottlieb, M.D. | Director | 53 | ["Member of board of directors since October 2019","Partner on NEA’s healthcare investment team since April 2019","Resident Fellow at American Enterprise Institute since April 2021","23rd Commissioner of the U.S. Food and Drug Administration from May 2017 to April 2019","Venture Partner at NEA from January 2007 to May 2017","Senior advisor to the Administrator of the Centers for Medicare and Medicaid Services in 2004","Contributor to CNBC and CBS News program Face the Nation","Executive committee member of Mount Sinai Health System’s board of directors","Co-chair of board’s education committee","Board member of Wesleyan University","Holds a B.A. from Wesleyan University and an M.D. from Mount Sinai School of Medicine","Extensive experience as a medical policy expert and public health advocate"] | ["Nominating and Corporate Governance Committee"] | 2026 |
| Theodore J. Leonsis | Director; Chair | 70 | ["General Partner at Revolution Growth","Founder, Chairman, Majority Owner, and CEO of Monumental Sports & Entertainment, LLC","Director of American Express Co. since July 2010","Director of Groupon, Inc. since June 2009","Bachelor’s degree from Georgetown University","Significant operational, investment and financial experience","Service on public company boards"] | ["Nominating and Corporate Governance Committee","Executive Committee"] | 2026 |
| Wayne A.I. Frederick, M.D. | Director | 54 | ["interim Chief Executive Officer of the American Cancer Society","served on the boards of directors of several other public companies","President Emeritus of Howard University","Charles R. Drew Endowed Chair of Surgery at Howard University’s College of Medicine","holds a B.S./M.D. dual degree","M.B.A. from Howard University","experience in medical research, healthcare academics and business administration"] | ["Audit Committee"] | 2026 |
